Plasma p-tau217 immunoassay offers accurate detection of Alzheimer’s disease pathology, supporting early diagnosis and ...

A GROUNDBREAKING phase 2b randomized clinical trial has demonstrated that plozasiran, an investigational APOC3-targeted siRNA ...

NOVEL research proposes a shift from clinical to biological definitions for Parkinson’s disease (PD) and dementia with Lewy ...

A RECENT study exploring the impact of multi-ancestry polygenic risk scores (PRS) on prostate cancer progression suggests ...

This phase 1–2, randomised, double-blind, placebo-controlled trial enrolled 130 patients aged 18 or older with confirmed ...

A GROUNDBREAKING study from earlier this year comparing the effectiveness of 7 Tesla (7T) MRI to the more widely used 3 Tesla ...

A STUDY evaluating the application of the 2017 McDonald criteria for diagnosing multiple sclerosis (MS) has shown that the ...

A groundbreaking study has shown that exagamglogene autotemcel (exa-cel), a CRISPR-based gene therapy, can effectively ...

A recent multicentre study has shown that venetoclax combined with decitabine as an effective first-line treatment for older ...

RESEARCH conducted earlier this year evaluating the performance of large language models (LLMs) in interpreting breast ...

A NEW study conducted at Sahlgrenska University Hospital, Gothenburg, Sweden, has revealed that dietary treatments may be ...

AI is set to revolutionise the detection of colorectal polyps during colonoscopies. Read findings from the COLO-DETECT trial.